<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000046136"><TermName>506U78</TermName><TermDefinition><DefinitionText>A drug used to treat certain types of T-cell acute lymphoblastic leukemia (T-ALL) and T-cell lymphoblastic lymphoma (T-LBL). It belongs to the family of drugs called antimetabolites. Also called Arranon and nelarabine.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><SpanishTermName>506U78</SpanishTermName><SpanishTermDefinition><DefinitionText>Medicamento usado para tratar ciertos tipos de leucemia linfoblástica aguda de células T (LLA-T) y linfoma linfoblástico de células T (LLB-T). Es un tipo de antimetabolito. También se llama Arranon y nelarabina.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateLastModified>2006-09-08</DateLastModified><RelatedInformation><RelatedDrugSummaryRef href="CDR0000492016">Nelarabine</RelatedDrugSummaryRef></RelatedInformation></GlossaryTerm>
